
Nucleic Acid Labeling Market By Product (Kits and Reagents, Services) , By Labeling Techniques (PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, End Labelling) By Application (DNA Sequencing, PCR, FISH, Microarray, In S
Description
Nucleic Acid Labeling Market By Product (Kits and Reagents, Services) , By Labeling Techniques (PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, End Labelling) By Application (DNA Sequencing, PCR, FISH, Microarray, In Situ Hybridization, Blotting, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Nucleic Acid Labeling Market
The nucleic acid labeling market was valued at $2.5 billion in 2023 and is projected to reach $5.1 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
Nucleic acid labeling is a biomolecular technique that involves the attachment of a detectable marker to nucleic acids, both DNA and RNA. This technique enables the tracking, analysis, or study of the presence, distribution, quantity, or sequence of nucleic acid. It finds applications in gene expression analysis, in-situ hybridization, PCR assays, and single-molecule analysis.
Rise in focus on genomic research and surge in the popularity of precision medicine are the key drivers of the nucleic acid labeling market. In addition, the technique plays a crucial role in facilitating early disease detection and proactive treatments, which augments the market growth significantly. Furthermore, expansion of the point-of-care testing approach is fueling the requirement for nucleic acid labeling infrastructure and propelling the development of the market. To enhance the precision and effectiveness of labeling, the development of next-generation fluorescent probes and nanoparticle-based labels is becoming a prominent trend in the market. These labels exhibit high sensitivity, which is essential to improve the signal-to-noise ratio of the process.
However, the high cost of reagents & equipment required to accomplish nucleic acid labeling deters several small-scale laboratories and institutions from their procurement, which hampers the growth of the market. Moreover, increase in the shortage of skilled workforce to conduct the labeling technique limits its adoption and restrains the nucleic acid labeling market. Contrarily, rise in expenditure and investments in the biopharmaceutical industry is poised to present lucrative opportunities for the nucleic acid labeling market. The technique is essential for the industry to discover, validate, and monitor the drugs, biomarkers, and therapeutic responses. According to IQVIA—an American professional consulting and biopharmaceutical development provider—the global funding for biopharmaceutical R&D upsurged from $61 billion in 2022 to $72 billion in 2023. Therefore, the nucleic acid labeling market is poised to witness several new avenues with increasing investments.
Segment Review
The nucleic acid labeling market is segmented into product, labeling techniques, application, and region. On the basis of product, the market is bifurcated into kits & reagents and services. Depending on labeling techniques, it is divided into PCR, nick translation, random primer, in-vitro transcription, reverse transcription, and end labelling. As per application, it is classified into DNA sequencing, PCR, FISH, microarray, in-situ hybridization, blotting, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of product, the kits & reagents & reagents segment held a high share of the market in 2023.
Depending on labeling techniques, the PCR segment dominated the market in 2023.
As per application, the FISH segment was the highest shareholder in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players in the global nucleic acid labeling market include Merck & Co., Inc., PerkinElmer, Inc., New England Biolabs, Inc., F. Hoffmann La-Roche AG, Enzo Biochem Inc., GE Healthcare, Vector Laboratories, Inc., Promega Corporation, Agilent Technologies, and Thermo Fisher Scientific. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Key Market Segments
By Product
Kits and Reagents
Services
By Labeling Techniques
PCR
Nick Translation
Random Primer
In Vitro Transcription
Reverse Transcription
End Labelling
By Application
DNA Sequencing
PCR
FISH
Microarray
In Situ Hybridization
Blotting
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Merck & Co., Inc.
PerkinElmer, Inc
New England Biolabs, Inc.
F. Hoffmann La-Roche AG
Enzo Biochem Inc.
GE Healthcare
vector laboratories, inc.
Promega Corporation
Agilent Technologies
Thermo Fisher Scientific
Table of Contents
280 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: NUCLEIC ACID LABELING MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Kits And Reagents
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Services
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Labeling Techniques
- 5.2. PCR
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Nick Translation
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Random Primer
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. In Vitro Transcription
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- 5.6. Reverse Transcription
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
- 5.7. End Labelling
- 5.7.1. Key Market Trends, Growth Factors and Opportunities
- 5.7.2. Market Size and Forecast, By Region
- 5.7.3. Market Share Analysis, By Country
- CHAPTER 6: NUCLEIC ACID LABELING MARKET, BY APPLICATION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Application
- 6.2. DNA Sequencing
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. PCR
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. FISH
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Microarray
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
- 6.6. In Situ Hybridization
- 6.6.1. Key Market Trends, Growth Factors and Opportunities
- 6.6.2. Market Size and Forecast, By Region
- 6.6.3. Market Share Analysis, By Country
- 6.7. Blotting
- 6.7.1. Key Market Trends, Growth Factors and Opportunities
- 6.7.2. Market Size and Forecast, By Region
- 6.7.3. Market Share Analysis, By Country
- 6.8. Others
- 6.8.1. Key Market Trends, Growth Factors and Opportunities
- 6.8.2. Market Size and Forecast, By Region
- 6.8.3. Market Share Analysis, By Country
- CHAPTER 7: NUCLEIC ACID LABELING MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Labeling Techniques
- 7.2.4. Market Size and Forecast, By Application
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Nucleic Acid Labeling Market
- 7.2.6.1. Market Size and Forecast, By Product
- 7.2.6.2. Market Size and Forecast, By Labeling Techniques
- 7.2.6.3. Market Size and Forecast, By Application
- 7.2.7. Canada Nucleic Acid Labeling Market
- 7.2.7.1. Market Size and Forecast, By Product
- 7.2.7.2. Market Size and Forecast, By Labeling Techniques
- 7.2.7.3. Market Size and Forecast, By Application
- 7.2.8. Mexico Nucleic Acid Labeling Market
- 7.2.8.1. Market Size and Forecast, By Product
- 7.2.8.2. Market Size and Forecast, By Labeling Techniques
- 7.2.8.3. Market Size and Forecast, By Application
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Labeling Techniques
- 7.3.4. Market Size and Forecast, By Application
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Nucleic Acid Labeling Market
- 7.3.6.1. Market Size and Forecast, By Product
- 7.3.6.2. Market Size and Forecast, By Labeling Techniques
- 7.3.6.3. Market Size and Forecast, By Application
- 7.3.7. France Nucleic Acid Labeling Market
- 7.3.7.1. Market Size and Forecast, By Product
- 7.3.7.2. Market Size and Forecast, By Labeling Techniques
- 7.3.7.3. Market Size and Forecast, By Application
- 7.3.8. UK Nucleic Acid Labeling Market
- 7.3.8.1. Market Size and Forecast, By Product
- 7.3.8.2. Market Size and Forecast, By Labeling Techniques
- 7.3.8.3. Market Size and Forecast, By Application
- 7.3.9. Italy Nucleic Acid Labeling Market
- 7.3.9.1. Market Size and Forecast, By Product
- 7.3.9.2. Market Size and Forecast, By Labeling Techniques
- 7.3.9.3. Market Size and Forecast, By Application
- 7.3.10. Spain Nucleic Acid Labeling Market
- 7.3.10.1. Market Size and Forecast, By Product
- 7.3.10.2. Market Size and Forecast, By Labeling Techniques
- 7.3.10.3. Market Size and Forecast, By Application
- 7.3.11. Rest Of Europe Nucleic Acid Labeling Market
- 7.3.11.1. Market Size and Forecast, By Product
- 7.3.11.2. Market Size and Forecast, By Labeling Techniques
- 7.3.11.3. Market Size and Forecast, By Application
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Labeling Techniques
- 7.4.4. Market Size and Forecast, By Application
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Nucleic Acid Labeling Market
- 7.4.6.1. Market Size and Forecast, By Product
- 7.4.6.2. Market Size and Forecast, By Labeling Techniques
- 7.4.6.3. Market Size and Forecast, By Application
- 7.4.7. China Nucleic Acid Labeling Market
- 7.4.7.1. Market Size and Forecast, By Product
- 7.4.7.2. Market Size and Forecast, By Labeling Techniques
- 7.4.7.3. Market Size and Forecast, By Application
- 7.4.8. Australia Nucleic Acid Labeling Market
- 7.4.8.1. Market Size and Forecast, By Product
- 7.4.8.2. Market Size and Forecast, By Labeling Techniques
- 7.4.8.3. Market Size and Forecast, By Application
- 7.4.9. India Nucleic Acid Labeling Market
- 7.4.9.1. Market Size and Forecast, By Product
- 7.4.9.2. Market Size and Forecast, By Labeling Techniques
- 7.4.9.3. Market Size and Forecast, By Application
- 7.4.10. South Korea Nucleic Acid Labeling Market
- 7.4.10.1. Market Size and Forecast, By Product
- 7.4.10.2. Market Size and Forecast, By Labeling Techniques
- 7.4.10.3. Market Size and Forecast, By Application
- 7.4.11. Rest of Asia-Pacific Nucleic Acid Labeling Market
- 7.4.11.1. Market Size and Forecast, By Product
- 7.4.11.2. Market Size and Forecast, By Labeling Techniques
- 7.4.11.3. Market Size and Forecast, By Application
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Labeling Techniques
- 7.5.4. Market Size and Forecast, By Application
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Nucleic Acid Labeling Market
- 7.5.6.1. Market Size and Forecast, By Product
- 7.5.6.2. Market Size and Forecast, By Labeling Techniques
- 7.5.6.3. Market Size and Forecast, By Application
- 7.5.7. Saudi Arabia Nucleic Acid Labeling Market
- 7.5.7.1. Market Size and Forecast, By Product
- 7.5.7.2. Market Size and Forecast, By Labeling Techniques
- 7.5.7.3. Market Size and Forecast, By Application
- 7.5.8. South Africa Nucleic Acid Labeling Market
- 7.5.8.1. Market Size and Forecast, By Product
- 7.5.8.2. Market Size and Forecast, By Labeling Techniques
- 7.5.8.3. Market Size and Forecast, By Application
- 7.5.9. Rest of LAMEA Nucleic Acid Labeling Market
- 7.5.9.1. Market Size and Forecast, By Product
- 7.5.9.2. Market Size and Forecast, By Labeling Techniques
- 7.5.9.3. Market Size and Forecast, By Application
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Merck And Co., Inc.
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. PerkinElmer, Inc
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. New England Biolabs, Inc.
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. F. Hoffmann La-Roche AG
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Enzo Biochem Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. GE Healthcare
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Vector Laboratories, Inc.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Promega Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Agilent Technologies
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Thermo Fisher Scientific
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. NUCLEIC ACID LABELING MARKET FOR KITS AND REAGENTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. NUCLEIC ACID LABELING MARKET FOR SERVICES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 5. NUCLEIC ACID LABELING MARKET FOR PCR, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. NUCLEIC ACID LABELING MARKET FOR NICK TRANSLATION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. NUCLEIC ACID LABELING MARKET FOR RANDOM PRIMER, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. NUCLEIC ACID LABELING MARKET FOR IN VITRO TRANSCRIPTION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. NUCLEIC ACID LABELING MARKET FOR REVERSE TRANSCRIPTION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. NUCLEIC ACID LABELING MARKET FOR END LABELLING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. GLOBAL NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 12. NUCLEIC ACID LABELING MARKET FOR DNA SEQUENCING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. NUCLEIC ACID LABELING MARKET FOR PCR, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. NUCLEIC ACID LABELING MARKET FOR FISH, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. NUCLEIC ACID LABELING MARKET FOR MICROARRAY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. NUCLEIC ACID LABELING MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 17. NUCLEIC ACID LABELING MARKET FOR BLOTTING, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 18. NUCLEIC ACID LABELING MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 19. NUCLEIC ACID LABELING MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 20. NORTH AMERICA NUCLEIC ACID LABELING MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 21. NORTH AMERICA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 22. NORTH AMERICA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 23. NORTH AMERICA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 24. U.S. NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 25. U.S. NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 26. U.S. NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 27. CANADA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 28. CANADA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 29. CANADA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 30. MEXICO NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 31. MEXICO NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 32. MEXICO NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 33. EUROPE NUCLEIC ACID LABELING MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 34. EUROPE NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 35. EUROPE NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 36. EUROPE NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 37. GERMANY NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 38. GERMANY NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 39. GERMANY NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 40. FRANCE NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 41. FRANCE NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 42. FRANCE NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 43. UK NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 44. UK NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 45. UK NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 46. ITALY NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 47. ITALY NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 48. ITALY NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 49. SPAIN NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 50. SPAIN NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 51. SPAIN NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 52. REST OF EUROPE NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 53. REST OF EUROPE NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 54. REST OF EUROPE NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 55. ASIA-PACIFIC NUCLEIC ACID LABELING MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 56. ASIA-PACIFIC NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 57. ASIA-PACIFIC NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 58. ASIA-PACIFIC NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 59. JAPAN NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 60. JAPAN NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 61. JAPAN NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 62. CHINA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 63. CHINA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 64. CHINA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 65. AUSTRALIA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 66. AUSTRALIA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 68. INDIA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 69. INDIA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 70. INDIA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 71. SOUTH KOREA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 72. SOUTH KOREA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 73. SOUTH KOREA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 74. REST OF ASIA-PACIFIC NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 75. REST OF ASIA-PACIFIC NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 76. REST OF ASIA-PACIFIC NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 77. LAMEA NUCLEIC ACID LABELING MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 78. LAMEA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 79. LAMEA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 80. LAMEA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 81. BRAZIL NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 82. BRAZIL NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 83. BRAZIL NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 84. SAUDI ARABIA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 85. SAUDI ARABIA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 86. SAUDI ARABIA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 87. SOUTH AFRICA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 88. SOUTH AFRICA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 89. SOUTH AFRICA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 90. REST OF LAMEA NUCLEIC ACID LABELING MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 91. REST OF LAMEA NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES, 2024 - 2033 ($BILLION)
- TABLE 92. REST OF LAMEA NUCLEIC ACID LABELING MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 93. MERCK AND CO., INC.: KEY EXECUTIVES
- TABLE 94. MERCK AND CO., INC.: COMPANY SNAPSHOT
- TABLE 95. MERCK AND CO., INC.: OPERATING SEGMENTS
- TABLE 96. MERCK AND CO., INC.: PRODUCT PORTFOLIO
- TABLE 97. MERCK AND CO., INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 98. PERKINELMER, INC: KEY EXECUTIVES
- TABLE 99. PERKINELMER, INC: COMPANY SNAPSHOT
- TABLE 100. PERKINELMER, INC: OPERATING SEGMENTS
- TABLE 101. PERKINELMER, INC: PRODUCT PORTFOLIO
- TABLE 102. PERKINELMER, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 103. NEW ENGLAND BIOLABS, INC.: KEY EXECUTIVES
- TABLE 104. NEW ENGLAND BIOLABS, INC.: COMPANY SNAPSHOT
- TABLE 105. NEW ENGLAND BIOLABS, INC.: OPERATING SEGMENTS
- TABLE 106. NEW ENGLAND BIOLABS, INC.: PRODUCT PORTFOLIO
- TABLE 107. NEW ENGLAND BIOLABS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 108. F. HOFFMANN LA-ROCHE AG: KEY EXECUTIVES
- TABLE 109. F. HOFFMANN LA-ROCHE AG: COMPANY SNAPSHOT
- TABLE 110. F. HOFFMANN LA-ROCHE AG: OPERATING SEGMENTS
- TABLE 111. F. HOFFMANN LA-ROCHE AG: PRODUCT PORTFOLIO
- TABLE 112. F. HOFFMANN LA-ROCHE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 113. ENZO BIOCHEM INC.: KEY EXECUTIVES
- TABLE 114. ENZO BIOCHEM INC.: COMPANY SNAPSHOT
- TABLE 115. ENZO BIOCHEM INC.: OPERATING SEGMENTS
- TABLE 116. ENZO BIOCHEM INC.: PRODUCT PORTFOLIO
- TABLE 117. ENZO BIOCHEM INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 118. GE HEALTHCARE: KEY EXECUTIVES
- TABLE 119. GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 120. GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 121. GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 122. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 123. VECTOR LABORATORIES, INC.: KEY EXECUTIVES
- TABLE 124. VECTOR LABORATORIES, INC.: COMPANY SNAPSHOT
- TABLE 125. VECTOR LABORATORIES, INC.: OPERATING SEGMENTS
- TABLE 126. VECTOR LABORATORIES, INC.: PRODUCT PORTFOLIO
- TABLE 127. VECTOR LABORATORIES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 128. PROMEGA CORPORATION: KEY EXECUTIVES
- TABLE 129. PROMEGA CORPORATION: COMPANY SNAPSHOT
- TABLE 130. PROMEGA CORPORATION: OPERATING SEGMENTS
- TABLE 131. PROMEGA CORPORATION: PRODUCT PORTFOLIO
- TABLE 132. PROMEGA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 133. AGILENT TECHNOLOGIES: KEY EXECUTIVES
- TABLE 134. AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
- TABLE 135. AGILENT TECHNOLOGIES: OPERATING SEGMENTS
- TABLE 136. AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
- TABLE 137. AGILENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 138. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
- TABLE 139. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
- TABLE 140. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
- TABLE 141. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
- TABLE 142. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL NUCLEIC ACID LABELING MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF NUCLEIC ACID LABELING MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN NUCLEIC ACID LABELING MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNUCLEIC ACID LABELING MARKET
- FIGURE 10. GLOBAL NUCLEIC ACID LABELING MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. NUCLEIC ACID LABELING MARKET FOR KITS AND REAGENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. NUCLEIC ACID LABELING MARKET FOR SERVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL NUCLEIC ACID LABELING MARKET SEGMENTATION, BY LABELING TECHNIQUES
- FIGURE 14. NUCLEIC ACID LABELING MARKET FOR PCR, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. NUCLEIC ACID LABELING MARKET FOR NICK TRANSLATION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. NUCLEIC ACID LABELING MARKET FOR RANDOM PRIMER, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. NUCLEIC ACID LABELING MARKET FOR IN VITRO TRANSCRIPTION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. NUCLEIC ACID LABELING MARKET FOR REVERSE TRANSCRIPTION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. NUCLEIC ACID LABELING MARKET FOR END LABELLING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. GLOBAL NUCLEIC ACID LABELING MARKET SEGMENTATION, BY APPLICATION
- FIGURE 21. NUCLEIC ACID LABELING MARKET FOR DNA SEQUENCING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. NUCLEIC ACID LABELING MARKET FOR PCR, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. NUCLEIC ACID LABELING MARKET FOR FISH, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. NUCLEIC ACID LABELING MARKET FOR MICROARRAY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 25. NUCLEIC ACID LABELING MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 26. NUCLEIC ACID LABELING MARKET FOR BLOTTING, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 27. NUCLEIC ACID LABELING MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 28. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 29. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 30. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 31. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 32. COMPETITIVE DASHBOARD
- FIGURE 33. COMPETITIVE HEATMAP: NUCLEIC ACID LABELING MARKET
- FIGURE 34. TOP PLAYER POSITIONING, 2023
- FIGURE 35. MERCK AND CO., INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 36. MERCK AND CO., INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 37. MERCK AND CO., INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 38. PERKINELMER, INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 39. PERKINELMER, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 40. PERKINELMER, INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 41. NEW ENGLAND BIOLABS, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 42. NEW ENGLAND BIOLABS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 43. NEW ENGLAND BIOLABS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 44. F. HOFFMANN LA-ROCHE AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 45. F. HOFFMANN LA-ROCHE AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 46. F. HOFFMANN LA-ROCHE AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 47. ENZO BIOCHEM INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 48. ENZO BIOCHEM INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 49. ENZO BIOCHEM INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 50. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
- FIGURE 51. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 52. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 53. VECTOR LABORATORIES, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 54. VECTOR LABORATORIES, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 55. VECTOR LABORATORIES, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 56. PROMEGA CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 57. PROMEGA CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 58. PROMEGA CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 59. AGILENT TECHNOLOGIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 60. AGILENT TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 61. AGILENT TECHNOLOGIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 62. THERMO FISHER SCIENTIFIC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 63. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 64. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2023 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.